Literature DB >> 24045622

Imaging hypoxia in tumours with advanced MRI.

J M Price1, S P Robinson, D M Koh.   

Abstract

Tumour hypoxia results in biological alterations that leads to a more aggressive disease phenotype and is associated with resistance to treatment. In this review, we discuss current magnetic resonance imaging techniques, which can be applied to evaluate tumour hypoxia, highlighting the principles of each technique, their pre-clinical and clinical deployment, as well as their strengths and limitations. The potential to combine these techniques, and also with other imaging modalities (e.g., PET imaging) using a multiparametric approach, may further improve our understanding of the complex interaction of vascular supply, oxygen diffusion and tissue metabolism in pathogenesis of tumour hypoxia; and its reversal with treatment.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24045622

Source DB:  PubMed          Journal:  Q J Nucl Med Mol Imaging        ISSN: 1824-4785            Impact factor:   2.346


  14 in total

Review 1.  PET radiopharmaceuticals for imaging of tumor hypoxia: a review of the evidence.

Authors:  Egesta Lopci; Ilaria Grassi; Arturo Chiti; Cristina Nanni; Gianfranco Cicoria; Luca Toschi; Cristina Fonti; Filippo Lodi; Sandro Mattioli; Stefano Fanti
Journal:  Am J Nucl Med Mol Imaging       Date:  2014-06-07

Review 2.  The clinical utility of imaging methods used to measure hypoxia in cervical cancer.

Authors:  Joseph Waller; Benjamin Onderdonk; Ann Flood; Harold Swartz; Jaffer Shah; Asghar Shah; Bulent Aydogan; Howard Halpern; Yasmin Hasan
Journal:  Br J Radiol       Date:  2020-04-22       Impact factor: 3.039

Review 3.  Tumor Microenvironment in Head and Neck Squamous Cell Carcinomas.

Authors:  Görkem Eskiizmir
Journal:  Turk Arch Otorhinolaryngol       Date:  2015-09-01

Review 4.  Imaging tumour hypoxia with oxygen-enhanced MRI and BOLD MRI.

Authors:  James P B O'Connor; Simon P Robinson; John C Waterton
Journal:  Br J Radiol       Date:  2019-01-24       Impact factor: 3.039

Review 5.  Redox- and hypoxia-responsive MRI contrast agents.

Authors:  Quyen N Do; James S Ratnakar; Zoltán Kovács; A Dean Sherry
Journal:  ChemMedChem       Date:  2014-05-13       Impact factor: 3.466

6.  Characterization of a clinically used charcoal suspension for in vivo EPR oximetry.

Authors:  Céline Marie Desmet; Ly Binh An Tran; Pierre Danhier; Bernard Gallez
Journal:  MAGMA       Date:  2018-09-12       Impact factor: 2.310

Review 7.  Hypoxia in cervical cancer: from biology to imaging.

Authors:  Heidi Lyng; Eirik Malinen
Journal:  Clin Transl Imaging       Date:  2017-07-10

Review 8.  Potential Coagulation Factor-Driven Pro-Inflammatory Responses in Ovarian Cancer Tissues Associated with Insufficient O₂ and Plasma Supply.

Authors:  Shiro Koizume; Yohei Miyagi
Journal:  Int J Mol Sci       Date:  2017-04-12       Impact factor: 5.923

Review 9.  Assessing Tumor Oxygenation for Predicting Outcome in Radiation Oncology: A Review of Studies Correlating Tumor Hypoxic Status and Outcome in the Preclinical and Clinical Settings.

Authors:  Florence Colliez; Bernard Gallez; Bénédicte F Jordan
Journal:  Front Oncol       Date:  2017-01-25       Impact factor: 6.244

10.  Delineation of Tumor Habitats based on Dynamic Contrast Enhanced MRI.

Authors:  Yu-Cherng Channing Chang; Ellen Ackerstaff; Yohann Tschudi; Bryan Jimenez; Warren Foltz; Carl Fisher; Lothar Lilge; HyungJoon Cho; Sean Carlin; Robert J Gillies; Yoganand Balagurunathan; Raphael L Yechieli; Ty Subhawong; Baris Turkbey; Alan Pollack; Radka Stoyanova
Journal:  Sci Rep       Date:  2017-08-29       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.